Here we show that SLE patients failed to generate robust SARS-CoV-2-specific protective antibody responses after two doses, including vaccine-specific IgG and IgA, and neutralizing capacity against the original strain of the virus and VoC. The gene discussed is CD79A; the disease is systemic lupus erythematosus.